CNO Financial Group, Inc. (CNOPA) stock analysis
Price, market cap and P/E appear here once daily prices are connected.
StockData Score
Prices as of Nov 6, 2026How the score works
Weak5 of 30 checks passed
CNO Financial passes 5 of the 30 checks behind our score; 18 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 1/6
- Past performance
- 4/6
- Financial health
- 0/6
- Dividend
- 0/6
What stands out
Return on equity over 15%
Return on equity was 16.9% over the last twelve months and averaged 15.2% over five years.
Earnings growth accelerating
Net income grew 30.8% over the last twelve months, against a 5-year average of -5.3% a year.
Return on assets over 1%
Return on assets was 1.1%; for a bank or insurer, 1% or more is considered good.
Return on equity above the industry
CNO Financial's return on equity of 16.9% is above the Accident and Health Insurance and Medical median of 11.9%.
What to watch
Earnings shrank over 5 years
Net income shrank 5.3% a year on average over the last five fiscal years.
Revenue growing under 10% a year
Revenue grew 7.9% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -24.6% a year over the last three fiscal years.
Interest not well covered
Operating income covers interest expense 3.1 times; we look for at least 5.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
P/S against the industry
Not enough revenue data to compare.
P/B against the industry
Needs positive book value.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth1/6
Revenue growing under 10% a year
Revenue grew 7.9% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -24.6% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 30.8% over the last twelve months, against a 5-year average of -5.3% a year.
Growing slower than the industry
Revenue grew 2.3% over the last twelve months; the Accident and Health Insurance and Medical median is 6.8%.
Guidance issued
The latest outlook (2026 operating earnings per share (EPS) guidance, Jul 30, 2026) was issued for the first time, so it neither adds nor takes away points.
Gross margin trend
Banks and insurers do not report gross profit.
Past performance4/6
Return on equity over 15%
Return on equity was 16.9% over the last twelve months and averaged 15.2% over five years.
Return on assets over 1%
Return on assets was 1.1%; for a bank or insurer, 1% or more is considered good.
Return on equity above the industry
CNO Financial's return on equity of 16.9% is above the Accident and Health Insurance and Medical median of 11.9%.
Earnings shrank over 5 years
Net income shrank 5.3% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 9.2% over the last twelve months, against a 5-year average of 10.5%.
Net margin above the industry
CNO Financial's net margin of 9.2% is above the Accident and Health Insurance and Medical median of 2.0%.
Financial health0/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt coverage
Needs operating cash flow.
Interest not well covered
Operating income covers interest expense 3.1 times; we look for at least 5.
Short-term liquidity
Insurers do not split assets into current and non-current.
Bankruptcy risk (Altman Z)
The Altman model does not apply to insurers.
Dividend0/6
No dividend
CNO Financial has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itWe don't publish a fair value for CNO Financial. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Margins
Share of revenue, fiscal years 2011 to 2025
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +0.9% | +7.9% | +3.3% | +1.6% | |
| Operating income | +0.4% | +5.8% | +3.6% | – | |
| Net income | -45.5% | -28.6% | -5.3% | -1.6% | |
| EPS, diluted | -40.9% | -24.6% | +1.7% | +5.2% | |
| Dividend per share | +6.3% | +6.8% | +7.3% | +9.5% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 8.3% | 5.9% | 8.9% | |
| Return on assets | 1.1% | 0.9% | 0.6% | |
| Interest coverage | – | 4.3× | 2.4× | |
| Diluted shares | 178M | 143M | 100M |
Cash use needs five years of cash flow figures
CNO Financial does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 5.1% | 0.12× | 14.87× | 8.9% |
| FY2024 | 9.5% | 0.12× | 15.40× | 17.8% |
| FY2023 | 6.7% | 0.12× | 17.11× | 13.9% |
| FY2022 | 17.6% | 0.10× | 12.71× | 23.1% |
| FY2021 | 13.8% | 0.12× | 7.80× | 12.4% |
| FY2020 | 7.9% | 0.11× | 6.79× | 5.9% |
| FY2019 | 10.2% | 0.12× | 8.08× | 10.2% |
| FY2018 | -7.3% | 0.13× | 7.85× | -7.7% |
| FY2017 | 4.1% | 0.13× | 6.97× | 3.8% |
| FY2016 | 9.0% | 0.13× | 7.32× | 8.3% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$229.30M
- Cash generatingOperating cash flow above zero$675.70M
- Return on assets improvedROA up on the prior year1.2% → 0.6%
- Earnings backed by cashOperating cash flow above net income$675.70M vs $229.30M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise108M → 100M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.13 → 0.12
See a number that looks wrong?